Some 28.3% (34/120) of the sample showed a PD‐L1 tumour proportion score (TPS) ≥1% by immunohistochemical analysis, and 32.5% (39/120) showed a PD‐L1 TPS <1%. Here, CD274 is linked to neoplasm.